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Background: Although antidepressant therapy has been related to 
increased cardiovascular risk, depression, and its adverse effects on 
prognosis, is a well-recognised entity among acute coronary syndrome 
(ACS) patients. The aim of the study was to evaluate prevalence and 
outcome of antidepressant treatment in a real-world cohort of ACS 
patients. 
Methods: We sought to assess the prevalence of established 
antidepressant therapy (ADT) and its impact among 2,168 all-comers 
patients admitted to four Swiss university hospitals for ACS and 
enrolled in the prospective multicentre SPUM registry (NCT01000701). 
The primary endpoint was all-cause mortality. The association between 
ADT and mortality was tested by adjusted multivariable conditional 
logistic regression. 
Results: Out of 2,168 ACS patients, 141 patients (6.5%) were on ADT. 
Compared with the general ACS population, ADT patients were more 
likely to be unemployed (p=0.001), men (p=0.002), diabetic (p=0.010) 
and already treated with cardiovascular (CV) preventive therapy with 
statins or beta-blockers (p<0.001). Patients with ADT had a twofold 
risk of all-cause mortality (OR 2.2, 95% CI [1.20–4.00[, p=0.009) with a 
threefold risk of non-CV death (OR 3.24, 95% CI [1.10–9.70], p=0.026) 
and a 77% not significant higher risk of CV death (OR 1.77, 95% CI 
[0.83–3.80], p=0.130). This enhanced risk persisted after adjustment for 
confounding significant baseline characteristics, with a 47% (adjusted 
HR 1.47, 95% CI [1.05–1.70], p=0.032, Figure 1). 
Conclusion: Among a real-world cohort of ACS patients, ADT is 
associated with a significantly increased rate of all-cause mortality 
and non-CV death. These observations should lead clinicians to further 
individualise ADT, employing newer and safer ADT, generally associated 
with a lower CV risk. n
Best Poster Award – Third Prize
The Perilousness of Antidepressant Drugs in a Real-world  
Cohort of Patients with Acute Coronary Syndrome
A Denegri,1 L Raeber,2 S Windecker,2 B Gencer,3 F Mach,3 N Rodondi,2  
D Heg,2 D Nanchen,4 C Matter5 and TF Luescher5 
1. Mantova, Italy; 2. Berne, Switzerland; 3. Geneva, Switzerland; 4. Lausanne, Switzerland; 5. Zurich, Switzerland
Citation: European Cardiology Review 2020;15:e26. DOI: https://doi.org/10.15420/ecr.2020.15.1.PO3
Open Access: This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for 
non-commercial purposes, provided the original work is cited correctly.
Figure 1.
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
7
4
6
7
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
